According to a recent study, risankizumab showed high complete-clearance rates long-term in adult psoriasis patients with extended-interval dosing in select stable responders.
Vitamin B5 derivative may be potential treatment for PsO
According to a recent study, patients taking tablets containing a vitamin B5 derivative known as pantethine experienced improved psoriasis symptoms.
Tildrakizumab linked to epigenetic age deviation in PsO patients
According to a recent study, psoriasis patients treated with tildrakizumab saw a reversal of epigenetic aging—changes in gene expression over time that are associated with increased mortality.
Zasocitinib effective in treating PsO in hard-to-treat areas
According to a recent press release, zasocitinib, an oral TYK2 inhibitor, is effective in improving skin clearance for psoriasis patients in hard-to-treat areas with once-daily treatment.
Exercise, diet, psychological interventions may complement conventional therapy for PsO
According to a recent study, lifestyle changes and nutritional interventions may complement conventional therapy for psoriasis patients.
PsO patients trust topicals less than AD patients
According to a recent study, trust levels regarding topical therapy were higher among atopic dermatitis (AD) patients than psoriasis (PsO) patients.
Text message intervention effective in improving cardiovascular risk in PsO patients
According to a recent study, a text message intervention system improved cardiovascular risk behaviours and patient confidence managing their health in adult psoriasis patients.
Concomitant ixekizumab, tirzepatide improves skin clearance, reduces weight in PsO patients
According to a recent study, concomitant ixekizumab and tirzepatide improved skin clearance and reductions in weight in patients with moderate-to-severe psoriasis.
Risankizumab linked to lower risk of serious infection than other systemic treatments
According to a recent study, risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis.
Researchers review relative efficacy of immunomodulatory therapies for scalp PsO
Researchers recently reviewed the relative efficacy of 22 immunomodulatory treatments, including placebo, for the treatment of scalp psoriasis.
